[Form 4] The Vita Coco Company, Inc. Insider Trading Activity
Kenneth Sadowsky, a director of The Vita Coco Company, Inc. (COCO), sold 3,900 shares of common stock under a Rule 10b5-1 trading plan on 08/20/2025 at a weighted average price of $35.448, with transaction prices ranging from $34.91 to $35.78. After the sale he beneficially owned 627,766 shares directly. The filing also reports a fully vested non-qualified stock option with a $10.178 exercise price covering 27,300 shares, exercisable through 01/02/2030. The Form 4 was signed by Alison Klein as attorney-in-fact on 08/22/2025. The filing indicates the sale was effected pursuant to a pre-established trading plan and discloses the weighted average and price range for the multiple trades executed.
Kenneth Sadowsky, amministratore di The Vita Coco Company, Inc. (COCO), ha venduto 3.900 azioni ordinarie con un piano di negoziazione ai sensi della Rule 10b5-1 in data 20/08/2025 a un prezzo medio ponderato di $35,448, con prezzi delle singole transazioni compresi tra $34,91 e $35,78. Dopo la vendita risultava proprietario beneficiario di 627.766 azioni direttamente. La comunicazione segnala inoltre un’opzione azionaria non qualificata completamente maturata con prezzo di esercizio $10,178 relativa a 27.300 azioni, esercitabile fino al 02/01/2030. Il Modulo 4 è stato firmato da Alison Klein in qualità di procuratore il 22/08/2025. Il documento precisa che la vendita è stata eseguita in base a un piano di negoziazione preesistente e riporta il prezzo medio ponderato e l’intervallo dei prezzi per le operazioni multiple effettuate.
Kenneth Sadowsky, director de The Vita Coco Company, Inc. (COCO), vendió 3.900 acciones ordinarias bajo un plan de negociación conforme a la Regla 10b5-1 el 20/08/2025 a un precio medio ponderado de $35,448, con precios de transacción que oscilaron entre $34,91 y $35,78. Tras la venta, poseía beneficiariamente 627.766 acciones de forma directa. La declaración también informa de una opción sobre acciones no calificada totalmente consolidada con precio de ejercicio de $10,178 que cubre 27.300 acciones, ejercitable hasta el 02/01/2030. El Formulario 4 fue firmado por Alison Klein como apoderada el 22/08/2025. El informe indica que la venta se realizó conforme a un plan de negociación preestablecido y divulga el precio medio ponderado y el rango de precios de las múltiples operaciones ejecutadas.
The Vita Coco Company, Inc.(COCO)의 이사 Kenneth Sadowsky는 2025-08-20에 Rule 10b5-1 거래 계획에 따라 보통주 3,900주를 가중평균 가격 $35.448에 매도했으며, 거래별 가격은 $34.91에서 $35.78 사이였습니다. 매도 후 그는 직접적으로 627,766주를 수익적으로 보유하고 있었습니다. 제출서류는 또한 행사 가격 $10.178로 27,300주를 대상으로 하는 완전 행사 가능 비자격 주식옵션이 있으며, 해당 옵션은 2030-01-02까지 행사할 수 있음을 보고하고 있습니다. Form 4는 2025-08-22에 Alison Klein이 법정대리인으로 서명했습니다. 제출서류는 이 매도가 사전에 설정된 거래 계획에 따라 이루어졌음을 밝히며, 다수 거래의 가중평균 및 가격 범위를 공시하고 있습니다.
Kenneth Sadowsky, administrateur de The Vita Coco Company, Inc. (COCO), a vendu 3 900 actions ordinaires dans le cadre d’un plan de trading Rule 10b5-1 le 20/08/2025 au prix moyen pondéré de 35,448 $, les prix des transactions individuelles variant de 34,91 $ à 35,78 $. Après la vente, il détenait directement 627 766 actions à titre bénéficiaire. Le dépôt signale également une option d’achat d’actions non qualifiée entièrement acquise au prix d’exercice de 10,178 $ couvrant 27 300 actions, exerçable jusqu’au 02/01/2030. Le formulaire 4 a été signé par Alison Klein en qualité de mandataire le 22/08/2025. Le document indique que la vente a été effectuée conformément à un plan de trading préétabli et divulgue le prix moyen pondéré ainsi que la fourchette de prix des multiples transactions exécutées.
Kenneth Sadowsky, ein Direktor von The Vita Coco Company, Inc. (COCO), verkaufte am 20.08.2025 im Rahmen eines Rule-10b5-1-Handelsplans 3.900 Stammaktien zu einem gewichteten Durchschnittspreis von $35,448; die einzelnen Transaktionen lagen zwischen $34,91 und $35,78. Nach dem Verkauf hielt er direkt 627.766 Aktien als wirtschaftlicher Eigentümer. Die Meldung berichtet außerdem über eine vollständig unverfallbare nicht qualifizierte Aktienoption mit einem Ausübungspreis von $10,178 auf 27.300 Aktien, ausübbar bis zum 02.01.2030. Das Formular 4 wurde am 22.08.2025 von Alison Klein als Bevollmächtigte unterschrieben. Die Einreichung gibt an, dass der Verkauf gemäß eines vorab festgelegten Handelsplans erfolgte und nennt den gewichteten Durchschnittspreis sowie die Preisspanne der ausgeführten Mehrfachtransaktionen.
- Sale executed under a Rule 10b5-1 trading plan, indicating the transaction was pre-arranged for compliance with insider trading rules
- Detailed price disclosure: weighted average price $35.448 and execution range $34.91 to $35.78 are provided
- Significant retained direct ownership after the sale: 627,766 shares remain beneficially owned
- Vested equity compensation disclosed: a fully vested non-qualified option for 27,300 shares at a $10.178 exercise price
- Reported disposition of shares: 3,900 shares were sold, reducing the reporting person’s holdings
- Potential dilution if the disclosed options are exercised: 27,300 underlying shares could increase outstanding shares
Insights
TL;DR: Director sold a small block under a 10b5-1 plan while retaining substantial holdings and holding vested options.
The reported sale of 3,900 shares appears to be routine and executed under a Rule 10b5-1 plan, which offers procedural protections and signals the trades were pre-planned rather than opportunistic. Post-transaction direct beneficial ownership of 627,766 shares shows continued alignment with shareholders. The disclosure of a fully vested non-qualified option exercisable until 01/02/2030 provides potential future dilution if exercised but also indicates long-term compensation remains in equity form. No other material events, such as large dispositions or abrupt departures, are reported.
TL;DR: Filing documents compliance with Section 16 and use of a 10b5-1 plan; transaction size is limited relative to disclosed holdings.
The Form 4 properly documents the director relationship, transaction date, and use of a 10b5-1 trading plan, which supports compliance with insider trading rules. The filing also transparently provides the weighted average sale price and the range of execution prices and includes a signature by an attorney-in-fact. The existence of vested options is disclosed, with clear exercise price and amount, helping stakeholders assess potential future equity issuance. No governance concerns such as unexplained accelerated sales or amendments are evident from the content provided.
Kenneth Sadowsky, amministratore di The Vita Coco Company, Inc. (COCO), ha venduto 3.900 azioni ordinarie con un piano di negoziazione ai sensi della Rule 10b5-1 in data 20/08/2025 a un prezzo medio ponderato di $35,448, con prezzi delle singole transazioni compresi tra $34,91 e $35,78. Dopo la vendita risultava proprietario beneficiario di 627.766 azioni direttamente. La comunicazione segnala inoltre un’opzione azionaria non qualificata completamente maturata con prezzo di esercizio $10,178 relativa a 27.300 azioni, esercitabile fino al 02/01/2030. Il Modulo 4 è stato firmato da Alison Klein in qualità di procuratore il 22/08/2025. Il documento precisa che la vendita è stata eseguita in base a un piano di negoziazione preesistente e riporta il prezzo medio ponderato e l’intervallo dei prezzi per le operazioni multiple effettuate.
Kenneth Sadowsky, director de The Vita Coco Company, Inc. (COCO), vendió 3.900 acciones ordinarias bajo un plan de negociación conforme a la Regla 10b5-1 el 20/08/2025 a un precio medio ponderado de $35,448, con precios de transacción que oscilaron entre $34,91 y $35,78. Tras la venta, poseía beneficiariamente 627.766 acciones de forma directa. La declaración también informa de una opción sobre acciones no calificada totalmente consolidada con precio de ejercicio de $10,178 que cubre 27.300 acciones, ejercitable hasta el 02/01/2030. El Formulario 4 fue firmado por Alison Klein como apoderada el 22/08/2025. El informe indica que la venta se realizó conforme a un plan de negociación preestablecido y divulga el precio medio ponderado y el rango de precios de las múltiples operaciones ejecutadas.
The Vita Coco Company, Inc.(COCO)의 이사 Kenneth Sadowsky는 2025-08-20에 Rule 10b5-1 거래 계획에 따라 보통주 3,900주를 가중평균 가격 $35.448에 매도했으며, 거래별 가격은 $34.91에서 $35.78 사이였습니다. 매도 후 그는 직접적으로 627,766주를 수익적으로 보유하고 있었습니다. 제출서류는 또한 행사 가격 $10.178로 27,300주를 대상으로 하는 완전 행사 가능 비자격 주식옵션이 있으며, 해당 옵션은 2030-01-02까지 행사할 수 있음을 보고하고 있습니다. Form 4는 2025-08-22에 Alison Klein이 법정대리인으로 서명했습니다. 제출서류는 이 매도가 사전에 설정된 거래 계획에 따라 이루어졌음을 밝히며, 다수 거래의 가중평균 및 가격 범위를 공시하고 있습니다.
Kenneth Sadowsky, administrateur de The Vita Coco Company, Inc. (COCO), a vendu 3 900 actions ordinaires dans le cadre d’un plan de trading Rule 10b5-1 le 20/08/2025 au prix moyen pondéré de 35,448 $, les prix des transactions individuelles variant de 34,91 $ à 35,78 $. Après la vente, il détenait directement 627 766 actions à titre bénéficiaire. Le dépôt signale également une option d’achat d’actions non qualifiée entièrement acquise au prix d’exercice de 10,178 $ couvrant 27 300 actions, exerçable jusqu’au 02/01/2030. Le formulaire 4 a été signé par Alison Klein en qualité de mandataire le 22/08/2025. Le document indique que la vente a été effectuée conformément à un plan de trading préétabli et divulgue le prix moyen pondéré ainsi que la fourchette de prix des multiples transactions exécutées.
Kenneth Sadowsky, ein Direktor von The Vita Coco Company, Inc. (COCO), verkaufte am 20.08.2025 im Rahmen eines Rule-10b5-1-Handelsplans 3.900 Stammaktien zu einem gewichteten Durchschnittspreis von $35,448; die einzelnen Transaktionen lagen zwischen $34,91 und $35,78. Nach dem Verkauf hielt er direkt 627.766 Aktien als wirtschaftlicher Eigentümer. Die Meldung berichtet außerdem über eine vollständig unverfallbare nicht qualifizierte Aktienoption mit einem Ausübungspreis von $10,178 auf 27.300 Aktien, ausübbar bis zum 02.01.2030. Das Formular 4 wurde am 22.08.2025 von Alison Klein als Bevollmächtigte unterschrieben. Die Einreichung gibt an, dass der Verkauf gemäß eines vorab festgelegten Handelsplans erfolgte und nennt den gewichteten Durchschnittspreis sowie die Preisspanne der ausgeführten Mehrfachtransaktionen.
FAQ
What did Kenneth Sadowsky disclose in the Form 4 for COCO?
Were the sales by Kenneth Sadowsky part of a pre-established plan?
Does Kenneth Sadowsky hold any stock options disclosed in the filing?
What prices were shares sold at according to the Form 4?
Who signed the Form 4 and when was it signed?
